Medicine
Citanest Plain 72 mg/1.8 mL injection
Citanest Plain 72 mg/1.8 mL injection is a prescription medicine containing Prilocaine for submucosal use, marketed by Dentsply Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Prilocaine
- Brand
- Citanest Plain
- Strength
- 72 mg/1.8 mL
- Dosage form
- Injection
- Route
- Submucosal
- Packs
- 50 cartridges of 1.8 mL
- Marketing authorisation holder
- Dentsply Pharmaceutical
- Manufacturer
- Dentsply Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BB04 Prilocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 November 1965
- Identifiers
- RxCUI 1012706, 1595048DailyMed set ID db23a56f-1e41-4843-9220-1b2e3059db41NDC 66312-630Application ANDA079235
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 cartridge in 1 carton / 1.8 mL in 1 cartridge | 66312-630-14 | Dentsply Pharmaceutical | 18 November 1965 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 November 1965 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Prilocaine is an amide local anesthetic indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. It is available as injection for submucosal use. MedsAcross supplies Prilocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PrilocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Citanest Plain prescribing information (Dentsply Pharmaceutical) · U.S. National Library of Medicine, DailyMed
Need Citanest Plain 72 mg/1.8 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.